These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 3552996)

  • 21. Bactericidal activity elicited by the beta C protein of group B streptococci contrasted with capsular polysaccharides.
    Fusco PC; Perry JW; Liang SM; Blake MS; Michon F; Tai JY
    Adv Exp Med Biol; 1997; 418():841-5. PubMed ID: 9331784
    [No Abstract]   [Full Text] [Related]  

  • 22. Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci.
    Baltimore RS; Kasper DL; Baker CJ; Goroff DK
    J Immunol; 1977 Feb; 118(2):673-8. PubMed ID: 65433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired chemotaxigenesis by type III group B streptococci in neonatal sera: relationship to diminished concentration of specific anticapsular antibody and abnormalities of serum complement.
    Anderson DC; Hughes BJ; Edwards MS; Buffone GJ; Baker CJ
    Pediatr Res; 1983 Jun; 17(6):496-502. PubMed ID: 6348689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance of Pasteurella multocida to rabbit neutrophil phagocytosis and killing.
    Rush HG; Glorioso JC; DaRif CA; Olson LC
    Am J Vet Res; 1981 Oct; 42(10):1760-8. PubMed ID: 7325438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pneumococcal intracellular killing is abolished by polysaccharide despite serum complement activity.
    Schweinle JE
    Infect Immun; 1986 Dec; 54(3):876-81. PubMed ID: 3781629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absolute requirement for complement in monoclonal IgM antibody-mediated protection against experimental infection with type III group B streptococci.
    Shigeoka AO; Jensen CL; Pincus SH; Hill HR
    J Infect Dis; 1984 Jul; 150(1):63-70. PubMed ID: 6379061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of complement receptors in opsonophagocytosis of group B streptococci by adult and neonatal neutrophils.
    Smith CL; Baker CJ; Anderson DC; Edwards MS
    J Infect Dis; 1990 Aug; 162(2):489-95. PubMed ID: 2197341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opsonization of Legionella pneumophila in human serum: key roles for specific antibodies and the classical complement pathway.
    Verbrugh HA; Lee DA; Elliott GR; Keane WF; Hoidal JR; Peterson PK
    Immunology; 1985 Apr; 54(4):643-53. PubMed ID: 3980045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody-dependent alternative pathway killing of Haemophilus influenzae type b.
    Steele NP; Munson RS; Granoff DM; Cummins JE; Levine RP
    Infect Immun; 1984 May; 44(2):452-8. PubMed ID: 6609128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bactericidal, bacteriolytic and opsonic activity of human serum against Escherichia coli.
    Rozenberg-Arska M; Porsius JC; Jaarsma EY; Verhoef J
    J Med Microbiol; 1986 Sep; 22(2):143-9. PubMed ID: 3528498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of antibody and complement in the bactericidal activity of mouse peritoneal exudate neutrophils.
    Hart PH; Spencer LK; Hill NL; McDonald PJ; Finlay-Jones JJ
    Br J Exp Pathol; 1987 Feb; 68(1):89-100. PubMed ID: 3545276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci.
    Marques MB; Kasper DL; Pangburn MK; Wessels MR
    Infect Immun; 1992 Oct; 60(10):3986-93. PubMed ID: 1398910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotypic diversity in the alpha C protein of group B streptococci.
    Madoff LC; Hori S; Michel JL; Baker CJ; Kasper DL
    Infect Immun; 1991 Aug; 59(8):2638-44. PubMed ID: 1855984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus.
    Edwards MS; Baker CJ; Kasper DL
    J Infect Dis; 1979 Dec; 140(6):1004-8. PubMed ID: 396335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitation of in vitro opsonic activity of human antibody induced by a vaccine consisting of the type III-specific polysaccharide of group B streptococcus.
    De Cueninck BJ; Eisenstein TK; McIntosh TS; Shockman GD; Swenson RM
    Infect Immun; 1983 Mar; 39(3):1155-60. PubMed ID: 6341229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of complement in opsonization of GBS.
    Edwards MS; Kasper DL; Nicholson-Weller A; Baker CJ
    Antibiot Chemother (1971); 1985; 35():170-89. PubMed ID: 3901894
    [No Abstract]   [Full Text] [Related]  

  • 37. Type III group B streptococcal strain differences in susceptibility to opsonization with human serum.
    Fischer GW; Hunter KW; Wilson SR
    Pediatr Res; 1981 Dec; 15(12):1525-9. PubMed ID: 7033908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new flow-cytometry-based opsonophagocytosis assay for the rapid measurement of functional antibody levels against Group B Streptococcus.
    Fabbrini M; Sammicheli C; Margarit I; Maione D; Grandi G; Giuliani MM; Mori E; Nuti S
    J Immunol Methods; 2012 Apr; 378(1-2):11-9. PubMed ID: 22309986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phagocytic and bactericidal activity of human neutrophils against two isolates of Group B streptococci Type Ic of differing pathogenicity.
    Cleat PH; Coid CR
    Br J Exp Pathol; 1981 Aug; 62(4):393-7. PubMed ID: 7028073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. L-ficolin and capsular polysaccharide-specific IgG in cord serum contribute synergistically to opsonophagocytic killing of serotype III and V group B streptococci.
    Fujieda M; Aoyagi Y; Matsubara K; Takeuchi Y; Fujimaki W; Matsushita M; Bohnsack JF; Takahashi S
    Infect Immun; 2012 Jun; 80(6):2053-60. PubMed ID: 22451515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.